⌘K
Loading ticker…
As of 2026-08-24, Perspective Therapeutics, Inc. (CATX) has a 3-month relative strength percentile of 20 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 45. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.1%, relative volume 0.59×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
CATX is held by 14 ETFs as of May 2026. Top owner: SCHA at 0.01% weight, $2M notional. Top 3 carry $4M.
Held by 27 ETFs · $44M across latest filings · largest weight 0.67% (PTH).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $2M | — |
| VTWO | 0.01% | $1M | — |
| VHTVanguard Health Care ETF | 0.01% | $1M | — |
| VFMO | 0.03% | $537K | new |
| AVSC | 0.01% | $346K | — |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $250K |
| — |
| VTWV | 0.01% | $188K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $16K | — |
| ITWO | 0.01% | $12K | — |
| URTY | 0.00% | $9K | — |
Showing 10 of 14 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CATX Jan avg: 50.19% median: 37.82% win: 100% σ: 46.35% n: 3 2023-02-22 → 2026-07-31 | CATX Feb avg: 7.00% median: 3.60% win: 50% σ: 27.20% n: 4 2023-02-22 → 2026-07-31 | CATX Mar avg: 15.21% median: 4.71% win: 50% σ: 47.51% n: 4 2023-02-22 → 2026-07-31 | CATX Apr avg: 11.82% median: 6.29% win: 50% σ: 21.68% n: 4 2023-02-22 → 2026-07-31 | CATX May avg: -6.69% median: -6.91% win: 50% σ: 11.33% n: 4 2023-02-22 → 2026-07-31 | CATX Jun avg: 4.67% median: 6.29% win: 50% σ: 29.93% n: 4 2023-02-22 → 2026-07-31 | CATX Jul avg: 4.68% median: -1.52% win: 50% σ: 24.52% n: 4 2023-02-22 → 2026-07-31 | CATX Aug avg: -8.42% median: -12.50% win: 33% σ: 22.84% n: 3 2023-02-22 → 2026-07-31 (current) | CATX Sep avg: -15.28% median: -15.51% win: 33% σ: 17.25% n: 3 2023-02-22 → 2026-07-31 | CATX Oct avg: -12.44% median: -11.54% win: 0% σ: 7.56% n: 3 2023-02-22 → 2026-07-31 | CATX Nov avg: -26.21% median: -13.92% win: 0% σ: 32.60% n: 3 2023-02-22 → 2026-07-31 | CATX Dec avg: 16.00% median: 17.02% win: 67% σ: 42.17% n: 3 2023-02-22 → 2026-07-31 |